JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bland, L. A.
Right arrow Articles by Favero, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bland, L. A.
Right arrow Articles by Favero, M. S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 582-588, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations

LA Bland, ME Villarino, MJ Arduino, SK McAllister, SM Gordon, CT Uyeda, C Valdon, D Potts, WR Jarvis and MS Favero
Nosocomial Infections Laboratory Branch, Centers for Disease Control, U.S. Department of Health and Human Services, Atlanta, Ga. 30333.

Autologous blood transfusion is a common method of reducing the need for heterologous blood transfusion during cardiac operations. Recently we investigated an outbreak of severe, nonsurgical postoperative bleeding among patients undergoing heart operations and receiving intraoperative transfusion of blood from a cell conservation device (Cell Saver System, Haemonetics Corp., Braintree, Mass.). As a result of this investigation, we conducted a prospective study to determine if bacterial or endotoxin contamination of the blood collected in the Cell Saver System and used for reinfusion during heart operations contributes to postoperative bleeding complications. Patients' blood samples were collected immediately before operation, at the end of cardiopulmonary bypass, 1 hour postoperatively, and from the Cell Saver System. All blood samples were cultured for bacteria, and all plasma samples were assayed for endotoxin. Preoperatively all patients having heart operations were without signs of infection, 33 of 37 blood cultures taken were negative, and none of the plasma samples had detectable endotoxin. After discontinuance of cardiopulmonary bypass but before delivery of blood from the Cell Saver System, bacteria and endotoxin were detected in 11 of 36 (30.6%) and five of 35 (14.3%) of the patients' blood samples, respectively. The blood aspirated from the open chest and collected by the Cell Saver System was culture positive in 30 of 31 (96.8%) samples, and seven of 29 (24.1%) contained endotoxin. One of 28 blood samples collected 1 hour postoperatively was culture positive, and five of 25 samples contained endotoxin. Of 61 total microorganisms isolated, 50 (82%) were coagulase-negative staphylococci, four (6.6%) aerobic diphtheroids, five (8.2%) anaerobic "diphtheroids" (Propionibacterium acnes), and two (3.2%) gram-negative bacilli. Plasma endotoxin concentrations ranged from 10 to 765 pg/ml. No signs of endotoxemia or unusual bleeding were observed intraoperatively or postoperatively in any of the 38 patients. Although blood collected in the Cell Saver System and used for reinfusion during heart operations often was contaminated with gram-positive bacterial commensals of the skin and low concentrations of endotoxin, no adverse effects were noted in the patients.


This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Shander, D. Moskowitz, and T. S. Rijhwani
The Safety and Efficacy of "Bloodless" Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 53 - 63.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Sakamoto, T. Ohmori, H. Takei, K. Hasuo, Y. Rino, and Y. Takanashi
Autologous salvaged blood transfusion in spontaneous hemopneumothorax
Ann. Thorac. Surg., August 1, 2004; 78(2): 705 - 707.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Dial, D. Nguyen, and D. Menzies
Autotransfusion of Shed Mediastinal Blood: A Risk Factor for Mediastinitis After Cardiac Surgery? Results of a Cluster Investigation
Chest, November 1, 2003; 124(5): 1847 - 1851.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M H Cross
Cell salvage and leucodepletion
Perfusion, January 1, 2001; 16(1_suppl): 61 - 66.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. Storck, K. Buttenschoen, D. Berger, A. Hannekum, and E. Boelke
Endotoxemia and Mediator Release During Cardiac Surgery
Angiology, September 1, 2000; 51(9): 743 - 749.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Reents, J. Babin-Ebell, M. R. Misoph, A. Schwarzkopf, and O. Elert
Influence of different autotransfusion devices on the quality of salvaged blood
Ann. Thorac. Surg., July 1, 1999; 68(1): 58 - 62.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. L. Quigley, J. T. Christenson, and G. G. Davies
Platelet-Rich Plasma Harvest in Redo CABG
Ann. Thorac. Surg., June 1, 1997; 63(6): 1828 - 1830.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
J. T. Christenson, J. Reuse, P. Badel, F. Simonet, and M. Schmuziger
Plateletpheresis Before Redo CABG Diminishes Excessive Blood Transfusion
Ann. Thorac. Surg., November 1, 1996; 62(5): 1373 - 1378.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The American Association for Thoracic Surgery.